Changes in Total IgE Plasma Concentration Measured at the Third Month during Anti-IgE Treatment Predict Future Exacerbation Rates in Difficult-to-Treat Atopic Asthma: A Pilot Study

By Negro Roberto W. Dal   Guerriero Massimo   Micheletto Claudio   Tognella Silvia   Visconti Marilia  

Journal of Asthma, Vol. 48, Iss. 5, 2011-06 ,pp. : 437-441

Informa Healthcare

Access to resources Recommend Favorite

Effect of Omalizumab as Add-On Therapy on Asthma-Related Quality of Life in Severe Allergic Asthma: A Brazilian Study (QUALITX)

By Rubin A.S   Souza-Machado A.   Andradre-Lima M.   Ferreira F.   Honda A.   Matozo T.M.  

Journal of Asthma, Vol. 49, Iss. 3, 2012-04 ,pp. : 288-293

Informa Healthcare

Access to resources Recommend Favorite

A subgroup analysis of the MONICA study: A 12-month, open-label study of add-on montelukast treatment in asthma patients

By Virchow J. Christian   Mehta Anish   Ljungblad Li   Mitfessel Harald  

Journal of Asthma, Vol. 47, Iss. 9, 2010-11 ,pp. : 986-993

Informa Healthcare

Access to resources Recommend Favorite

Cost-Utility Analysis of the Inhaled Steroids Available in a Developing Country for the Management of Pediatric Patients with Persistent Asthma

By Rodríguez-Martínez Carlos E.  

Journal of Asthma, Vol. 50, Iss. 4, 2013-05 ,pp. : 410-418

Informa Healthcare

Access to resources Recommend Favorite

High Prevalence of Skin Test Positivity in Severe or Difficult-to-Treat Asthma

By Haselkorn Tmirah   Borish Larry   Miller Dave   Weiss Scott   Wong Dennis   Group TENOR Study  

Journal of Asthma, Vol. 43, Iss. 10, 2006-12 ,pp. : 745-752

Informa Healthcare

Access to resources Recommend Favorite